A carregar...
An open-label study of escitalopram in body dysmorphic disorder
Body dysmorphic disorder (BDD) is a relatively common and impairing disorder. Selective serotonin reuptake inhibitors (SRIs) appear selectively efficacious for BDD, but pharmacotherapy research is limited, and escitalopram has not been studied. Fifteen subjects with BDD were treated with escitalopra...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1613831/ https://ncbi.nlm.nih.gov/pubmed/16528140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.yic.0000194378.65460.ef |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|